|
1
|
Xu-Welliver M and Carbone DP: Blood-based
biomarkers in lung cancer: Prognosis and treatment decisions.
Transl Lung Cancer Res. 6:708–712. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cha G, Xu J, Xu X, Li B, Lu S, Nanding A,
Hu S and Liu S: High expression of CIP2A protein is associated with
tumor aggressiveness in stage I–III NSCLC and correlates with poor
prognosis. Onco Targets Ther. 10:5907–5914. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arbour KC and Riely GJ: Systemic therapy
for locally advanced and metastatic non-small cell lung cancer: A
review. JAMA. 322:764–774. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang Z, Wang H, Xia L, Oyang L, Zhou Y,
Zhang B, Chen X, Luo X, Liao Q and Liang J: Overexpression of PAK1
correlates with aberrant expression of EMT markers and poor
prognosis in non-small cell lung cancer. J Cancer. 8:1484–1491.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rokavec M, Kaller M, Horst D and Hermeking
H: Pan-cancer EMT-signature identifies RBM47 down-regulation during
colorectal cancer progression. Sci Rep. 7:46872017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Krebs AM, Mitschke J, Lasierra Losada M,
Schmalhofer O, Boerries M, Busch H, Boettcher M, Mougiakakos D,
Reichardt W, Bronsert P, et al: The EMT-activator Zeb1 is a key
factor for cell plasticity and promotes metastasis in pancreatic
cancer. Nat Cell Biol. 19:518–529. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tong D, Liu Q, Liu G, Xu J, Lan W, Jiang
Y, Xiao H, Zhang D and Jiang J: Metformin inhibits
castration-induced EMT in prostate cancer by repressing
COX2/PGE2/STAT3 axis. Cancer Lett. 389:23–32. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ye X, Brabletz T, Kang Y, Longmore GD,
Nieto MA, Stanger BZ, Yang J and Weinberg RA: Upholding a role for
EMT in breast cancer metastasis. Nature. 547:E1–E3. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Baek SH, Ko JH, Lee JH, Kim C, Lee H, Nam
D, Lee J, Lee SG, Yang WM, Um JY, et al: Ginkgolic acid inhibits
invasion and migration and TGF-β-induced EMT of lung cancer cells
through PI3K/Akt/mTOR inactivation. J Cell Physiol. 232:346–354.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Otsuki Y, Saya H and Arima Y: Prospects
for new lung cancer treatments that target EMT signaling. Dev Dyn.
247:462–472. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ricciuti B, Mencaroni C, Paglialunga L,
Paciullo F, Crinò L, Chiari R and Metro G: Long noncoding RNAs: New
insights into non-small cell lung cancer biology, diagnosis and
therapy. Med Oncol. 33:182016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gong WJ, Peng JB, Yin JY, Li XP, Zheng W,
Xiao L, Tan LM, Xiao D, Chen YX, Li X, et al: Association between
well-characterized lung cancer lncRNA polymorphisms and
platinum-based chemotherapy toxicity in Chinese patients with lung
cancer. Acta Pharmacol Sin. 38:581–590. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tan BS, Yang MC, Singh S, Chou YC, Chen
HY, Wang MY, Wang YC and Chen RH: LncRNA NORAD is repressed by the
YAP pathway and suppresses lung and breast cancer metastasis by
sequestering S100P. Oncogene. 38:5612–5626. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen T, Qin S, Gu Y, Pan H and Bian D:
Long non-coding RNA NORAD promotes the occurrence and development
of non-small cell lung cancer by adsorbing MiR-656-3p. Mol Genet
Genomic Med. 7:e7572019. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao W, Weng T, Wang L, Shi B, Meng W, Wang
X, Wu Y, Jin L and Fei L: Long noncoding RNA NORAD promotes cell
proliferation and glycolysis in nonsmall cell lung cancer by acting
as a sponge for miR1365p. Mol Med Rep. 19:5397–5405.
2019.PubMed/NCBI
|
|
17
|
Zou Y, Chen Y, Yao S, Deng G, Liu D, Yuan
X, Liu S, Rao J, Xiong H, Yuan X, et al: MiR-422a weakened breast
cancer stem cells properties by targeting PLP2. Cancer Biol Ther.
19:436–444. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jin X and Xie C: MA02. 07 Evaluation of
exosomal miRNAs from plasma as potential biomarker for NSCLC. J
Thoracic Oncol. 12 (Suppl):S350–S351. 2017. View Article : Google Scholar
|
|
19
|
Li H, Wang X, Wen C, Huo Z, Wang W, Zhan
Q, Cheng D, Chen H, Deng X, Peng C and Shen B: Long noncoding RNA
NORAD, a novel competing endogenous RNA, enhances the
hypoxia-induced epithelial-mesenchymal transition to promote
metastasis in pancreatic cancer. Mol Cancer. 16:1692017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang X, Cai JB, Peng R, Wei CY, Lu JC, Gao
C, Shen ZZ, Zhang PF, Huang XY, Ke AW, et al: The long noncoding
RNA NORAD enhances the TGF-β pathway to promote hepatocellular
carcinoma progression by targeting miR-202-5p. J Cell Physiol.
234:12051–12060. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zuo ZK, Gong Y, Chen XH, Ye F, Yin ZM,
Gong QN and Huang JS: TGFβ1-induced LncRNA UCA1 upregulation
promotes gastric cancer invasion and migration. DNA Cell Biol.
36:159–167. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feng SQ, Zhang XY, Fan HT, Sun QJ and
Zhang M: Up-regulation of LncRNA MEG3 inhibits cell migration and
invasion and enhances cisplatin chemosensitivity in bladder cancer
cells. Neoplasma. 65:925–932. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu M, Chen X, Lin K, Zeng K, Liu X, Pan B,
Xu X, Xu T, Hu X, Sun L, et al: The long noncoding RNA SNHG1
regulates colorectal cancer cell growth through interactions with
EZH2 and miR-154-5p. Mol Cancer. 17:1412018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li L, Wang Y, Zhang X, Huang Q, Diao Y,
Yin H and Liu H: Long non-coding RNA HOXD-AS1 in cancer. Clin Chim
Acta. 487:197–201. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou K, Ou Q, Wang G, Zhang W, Hao Y and
Li W: High long non-coding RNA NORAD expression predicts poor
prognosis and promotes breast cancer progression by regulating
TGF-β pathway. Cancer Cell Int. 19:632019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tong L, Ao Y, Zhang H, Wang K, Wang Y and
Ma Q: Long noncoding RNA NORAD is upregulated in epithelial ovarian
cancer and its downregulation suppressed cancer cell functions by
competing with miR-155-5p. Cancer Med. 8:4782–4791. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang X, Zou J, Chen H, Zhang P, Lu Z, You
Z and Sun J: Long noncoding RNA NORAD regulates cancer cell
proliferation and migration in human osteosarcoma by endogenously
competing with miR-199a-3p. IUBMB Life. 71:1482–1491. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tao W, Li Y, Zhu M, Li C and Li P: LncRNA
NORAD promotes proliferation and inhibits apoptosis of gastric
cancer by regulating miR-214/Akt/mTOR axis. Onco Targets Ther.
12:8841–8851. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang H and Guo H: Long non-coding RNA
NORAD induces cell proliferation and migration in prostate cancer.
J Int Med Res. 47:3898–3904. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang X, Yan Y, Chen Y, Li J and Yang J:
Involvement of NORAD/miR-608/STAT3 axis in carcinostasis effects of
physcion 8-O-β-glucopyranoside on ovarian cancer cells. Artif Cells
Nanomed Biotechnol. 47:2855–2865. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu J, Li H, Zheng B, Sun L, Yuan Y and
Xing C: Competitive endogenous RNA (ceRNA) regulation network of
lncRNA-miRNA-mRNA in colorectal carcinogenesis. Dig Dis Sci.
64:1868–1877. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
He Z, Li Z, Zhang X, Yin K, Wang W, Xu Z,
Li B, Zhang L, Xu J, Sun G, et al: MiR-422a regulates cellular
metabolism and malignancy by targeting pyruvate dehydrogenase
kinase 2 in gastric cancer. Cell Death Dis. 9:5052018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yan DG, Liu N, Chao M, Tu YY and Liu WS:
SP1-induced upregulation of long noncoding RNA LINC00313
contributes to papillary thyroid cancer progression via the
miR-422a. Eur Rev Med Pharmacol Sci. 23:1134–1144. 2019.PubMed/NCBI
|
|
34
|
Li WQ, Zhang JP, Wang YY, Li XZ and Sun L:
MicroRNA-422a functions as a tumor suppressor in non-small cell
lung cancer through SULF2-mediated TGF-β/SMAD signaling pathway.
Cell Cycle. 18:1727–1744. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu SP, Wang JY, Wang XG and Zhao JP: Long
intergenic non-protein coding RNA 00858 functions as a competing
endogenous RNA for miR-422a to facilitate the cell growth in
non-small cell lung cancer. Aging. 9:475–486. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pastushenko I, Brisebarre A, Sifrim A,
Fioramonti M, Revenco T, Boumahdi S, Van Keymeulen A, Brown D,
Moers V, Lemaire S, et al: Identification of the tumour transition
states occurring during EMT. Nature. 556:463–468. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mahmood MQ, Ward C, Muller HK, Sohal SS
and Walters EH: Epithelial mesenchymal transition (EMT) and
non-small cell lung cancer (NSCLC): A mutual association with
airway disease. Med Oncol. 34:452017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang F, Yu N, Wang H, Zhang C, Zhang Z, Li
Y, Li D, Yan L, Liu H and Xu Z: Downregulated expression of
hepatoma-derived growth factor inhibits migration and invasion of
prostate cancer cells by suppressing epithelial-mesenchymal
transition and MMP2, MMP9. PLoS One. 13:e01907252018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Paolillo M and Schinelli S: Extracellular
matrix alterations in metastatic processes. Int J Mol Sci.
20:49472019. View Article : Google Scholar
|
|
40
|
Noh MG, Oh SJ, Ahn EJ, Kim YJ, Jung TY,
Jung S, Kim KK, Lee JH, Lee KH and Moon KS: Prognostic significance
of E-cadherin and N-cadherin expression in Gliomas. BMC Cancer.
17:5832017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liao S, Yu C, Liu H, Zhang C, Li Y and
Zhong X: Long non-coding RNA H19 promotes the proliferation and
invasion of lung cancer cells and regulates the expression of
E-cadherin, N-cadherin, and vimentin. Onco Targets Ther.
12:4099–4107. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yu SY, Peng H, Zhu Q, Wu YX, Wu F, Han CR,
Yan B, Li Q and Xiang HG: Silencing the long noncoding RNA NORAD
inhibits gastric cancer cell proliferation and invasion by the
RhoA/ROCK1 pathway. Eur Rev Med Pharmacol Sci. 23:3760–3770.
2019.PubMed/NCBI
|
|
43
|
Wu L, Hu B, Zhao B, Liu Y, Yang Y, Zhang L
and Chen J: Circulating microRNA-422a is associated with lymphatic
metastasis in lung cancer. Oncotarget. 8:42173–42188. 2017.
View Article : Google Scholar : PubMed/NCBI
|
